A VC’s take on the Genomic Age
Mohr Davidow Ventures partner Bill Ericson, who helped fund high-speed genome-sequencer Pacific Biosciences, is a big believer in the emerging Age of Genomics and its potential to transform medicine, health insurance and our understanding of ourselves.
Check out my recent Q&A with the venture capitalist over at VentureBeat Life Sciences for a conversation that also features digressions on the likelihood that we’ll end up living in a Gattaca-style dystopia and why most people taking cholesterol-lowering statins should chuck them instead.
Next Story: Bunchball learns from games on Facebook, creates its own for shows like The Office
Previous Story: Agami Systems takes $45M for network storage
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.